Smith Shellnut Wilson’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$416K Sell
2,649
-302
-10% -$46.6K 0.16% 88
2025
Q2
$496K Sell
2,951
-1,448
-33% -$215K 0.22% 70
2025
Q1
$606K Buy
4,399
+91
+2% +$11.6K 0.28% 62
2024
Q4
$510K Buy
4,308
+168
+4% +$19.6K 0.23% 73
2024
Q3
$458K Hold
4,140
0.21% 77
2024
Q2
$407K Hold
4,140
0.2% 82
2024
Q1
$463K Hold
4,140
0.25% 73
2023
Q4
$417K Sell
4,140
-53
-1% -$5.26K 0.24% 75
2023
Q3
$364K Hold
4,193
0.22% 77
2023
Q2
$397K Sell
4,193
-51
-1% -$4.31K 0.22% 79
2023
Q1
$320K Hold
4,244
0.19% 90
2022
Q4
$326K Buy
4,244
+7
+0.2% +$532 0.2% 91
2022
Q3
$283K Buy
4,237
+31
+0.7% +$1.97K 0.19% 95
2022
Q2
$220K Sell
4,206
-371
-8% -$21.1K 0.14% 119
2022
Q1
$260K Buy
4,577
+73
+2% +$3.91K 0.14% 122
2021
Q4
$232K Buy
4,504
+83
+2% +$4.07K 0.11% 137
2021
Q3
$219K Buy
4,421
+87
+2% +$4.72K 0.13% 133
2021
Q2
$247K Sell
4,334
-218
-5% -$12.7K 0.14% 122
2021
Q1
$277K Sell
4,552
-353
-7% -$19.5K 0.17% 107
2020
Q4
$263K Buy
+4,905
New +$255K 0.16% 105
2020
Q1
Sell
-4,592
Closed -$232K 127
2019
Q4
$232K Hold
4,592
0.15% 115
2019
Q3
$217K Buy
+4,592
New +$210K 0.16% 116
2018
Q4
Sell
-3,757
Closed -$203K 115
2018
Q3
$203K Buy
+3,757
New +$192K 0.18% 116
2018
Q1
$235K Buy
3,757
+190
+5% +$13K 0.2% 109
2017
Q4
$219K Buy
3,567
+199
+6% +$12.3K 0.19% 118
2017
Q3
$225K Buy
+3,368
New +$238K 0.2% 121

Other funds holding CAH

Smith Shellnut Wilson's CAH Position: Q3 2025 in Review

Smith Shellnut Wilson reduced its Cardinal Health (CAH) stake by 10% in Q3 2025, selling an estimated $46.6K and leaving 2,649 shares worth $416K. The position accounts for 0.16% of the portfolio, ranked #88.

Smith Shellnut Wilson first reported a position in CAH in Q3 2017 and has held it in 26 quarters since. The position peaked at $606K in Q1 2025. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Smith Shellnut Wilson held 2,649 shares of Cardinal Health worth $416K as of Q3 2025.
  • Smith Shellnut Wilson sold 302 Cardinal Health shares in Q3 2025, an estimated $46.6K.
  • Cardinal Health made up 0.16% of Smith Shellnut Wilson's portfolio in Q3 2025, its #88 holding.
  • Smith Shellnut Wilson first reported a position in Cardinal Health in Q3 2017 and has held it in 26 quarters since.
  • Smith Shellnut Wilson's Cardinal Health position peaked at $606K in Q1 2025.
  • 1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Smith Shellnut Wilson's 13F filing for Q3 2025, filed 27 Oct 2025.